awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35506764-110D6AB6-6EE6-4A7E-AE51-1EDA1943B8F6
Q35506764-110D6AB6-6EE6-4A7E-AE51-1EDA1943B8F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35506764-110D6AB6-6EE6-4A7E-AE51-1EDA1943B8F6
In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma.
P2860
Q35506764-110D6AB6-6EE6-4A7E-AE51-1EDA1943B8F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35506764-110D6AB6-6EE6-4A7E-AE51-1EDA1943B8F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f88158ec4b477f75a1e9c1d195e0427c7d2e3154
P2860
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies